Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InMode
Yokneam, Israelinmodemd.com ↗
- Ownership
- Public · INMD
- Development stage
- Other
01
Overview
InMode’s devices are FDA-cleared and commercially available for a range of minimally invasive and non-invasive aesthetic procedures. The company has demonstrated strong commercial adoption globally with significant revenue growth over recent years[4][5].
- Therapeutic areas
- Women's HealthDermatology
- Modalities
- DeviceNon-pharmacological therapy (including Radiofrequency device, Laser device, IPL device)
- Industry
- Therapeutic Medical Devices
02
Financials
- Market cap
- $771.1M
- Total revenue
- $370.5M
- Enterprise value
- $274.4M
Beyond the preview
Go deeper on InMode.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InMode.